Danielle Johnson, MD
Psychiatry · Mason, OHNPI 1356552665
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,354 of the $17,544 with a category attached, or 64.7%. Biogen accounts for 98.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $17,206 and has fallen 99.9% since, to $24 in 2025. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $730.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$17K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$175
- Sage Therapeutics, LLC$30
- E.r. Squibb & Sons, L.L.C.$24
- Otsuka America Pharmaceutical, Inc.$22
- AbbVie$16
What the payments were for
- Consulting fees$11,35465%
- Speaking & faculty fees$4,63126%
- Travel & lodging$1,1186%
- Food & beverage$4413%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 19 | $17,276 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $175 |
| Sage Therapeutics, LLC | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zurzuvae$16,549
- ABILIFY MYCITE$175
How this compares
$17,544 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wellbutrin XlBupropion Hcl | 11 | $27,555 |
| Lurasidone Hcl | 11 | $11,222 |
| Adderall XrDextroamphetamine/Amphetamine | 20 | $4,877 |
| Aripiprazole | 16 | $2,990 |
| Vilazodone Hcl | 13 | $1,981 |
| Quetiapine Fumarate | 16 | $1,399 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 28 | $970 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $949 |
| Pregabalin | 16 | $779 |
| Bupropion XlBupropion Hcl | 27 | $529 |
| Oxycodone Hcl | 12 | $485 |
| Clonazepam | 50 | $430 |
| Lamotrigine | 18 | $333 |
| Trazodone Hcl | 37 | $318 |
| Sertraline Hcl | 25 | $297 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Mason
- Susan McElroyMason$39K
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
- Paul KeckCincinnati$739K
- Ali MelhemSteubenville$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.